Found: 11
Select item for more details and to access through your institution.
Lower relapse incidence with HAPLO versus MSD or MUD HCTs for AML patients with KMT2A rearrangement: a study from the Global Committee and the ALWP of the EBMT.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01072-0
- By:
- Publication type:
- Article
Bayesian interim analysis for prospective randomized studies: reanalysis of the acute myeloid leukemia HOVON 132 clinical trial.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01037-3
- By:
- Publication type:
- Article
Cord blood transplantation for AML: Comparable LFS in patients with de novo versus secondary AML in CR1, an ALWP/EBMT study.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 1, p. 250, doi. 10.1111/bjh.19130
- By:
- Publication type:
- Article
Oculocerebrorenal syndrome of Lowe protein controls cytoskeletal reorganisation during human platelet spreading.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 1, p. 87, doi. 10.1111/bjh.18478
- By:
- Publication type:
- Article
Complex karyotype but not other cytogenetic abnormalities is associated with worse posttransplant survival of patients with nucleophosmin 1‐mutated acute myeloid leukemia: A study from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 3, p. 360, doi. 10.1002/ajh.27187
- By:
- Publication type:
- Article
Pretreatment clinical and genetic factors predict early post‐treatment mortality in fit AML patients following induction.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 7, p. E259, doi. 10.1002/ajh.26188
- By:
- Publication type:
- Article
Benefits and risks of clofarabine in adult acute lymphoblastic leukemia investigated in depth by multi‐state modeling.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 9, p. 1, doi. 10.1002/cam4.6756
- By:
- Publication type:
- Article
The added value of multi‐state modelling in a randomized controlled trial: The HOVON 102 study re‐analyzed.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 3, p. 630, doi. 10.1002/cam4.4392
- By:
- Publication type:
- Article
Comparative Value of Post-Remission Treatment in Cytogenetically Normal AML Subclassified by NPM1 and FLT3-ITD Allelic Ratio.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S27, doi. 10.1016/j.clml.2016.07.039
- By:
- Publication type:
- Article
Therapeutic Drug Monitoring of Kinase Inhibitors in Oncology.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 10, p. 1333, doi. 10.1007/s40262-023-01293-9
- By:
- Publication type:
- Article
Prognostic impact of number of induction courses to attain complete remission in patients with acute myeloid leukemia transplanted with either a matched sibling or human leucocyte antigen 10/10 or 9/10 unrelated donor: An Acute Leukemia Working Party European Society for Blood and Marrow Transplantation study
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 15, p. 2642, doi. 10.1002/cncr.35308
- By:
- Publication type:
- Article